Cargando…

High-Dose Dexmedetomidine for Severe Hyperactive Delirium Secondary to Intravenous Levetiracetam on Two Separate Occasions in the Same Patient

We describe the case of a 5-year-old male who developed severe hyperactive delirium with aggressive violent behavior following the administration of IV levetiracetam for the treatment of status epilepticus on two occasions. The child's symptoms ranged from attacking his parents and the intensiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Ward, Chad, Khalid, Kiran, Rozette, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271000/
https://www.ncbi.nlm.nih.gov/pubmed/35818414
http://dx.doi.org/10.1155/2022/1843774
_version_ 1784744584208711680
author Ward, Chad
Khalid, Kiran
Rozette, Nicole
author_facet Ward, Chad
Khalid, Kiran
Rozette, Nicole
author_sort Ward, Chad
collection PubMed
description We describe the case of a 5-year-old male who developed severe hyperactive delirium with aggressive violent behavior following the administration of IV levetiracetam for the treatment of status epilepticus on two occasions. The child's symptoms ranged from attacking his parents and the intensive care staff. Risperidone was given without any improvement in symptoms. A high-dose continuous infusion of IV dexmedetomidine was administered, and his violent behavior and delirium significantly improved. The two episodes of hyperactive delirium following IV levetiracetam administration occurred at ages 3 and 5, resulting in extensive work up including laboratory testing and cranial imaging, along with cerebral spinal fluid analysis and were normal. IV dexmedetomidine provided rapid symptom relief to prevent harm for the child, staff, and family on both occasions.
format Online
Article
Text
id pubmed-9271000
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-92710002022-07-10 High-Dose Dexmedetomidine for Severe Hyperactive Delirium Secondary to Intravenous Levetiracetam on Two Separate Occasions in the Same Patient Ward, Chad Khalid, Kiran Rozette, Nicole Case Rep Psychiatry Case Report We describe the case of a 5-year-old male who developed severe hyperactive delirium with aggressive violent behavior following the administration of IV levetiracetam for the treatment of status epilepticus on two occasions. The child's symptoms ranged from attacking his parents and the intensive care staff. Risperidone was given without any improvement in symptoms. A high-dose continuous infusion of IV dexmedetomidine was administered, and his violent behavior and delirium significantly improved. The two episodes of hyperactive delirium following IV levetiracetam administration occurred at ages 3 and 5, resulting in extensive work up including laboratory testing and cranial imaging, along with cerebral spinal fluid analysis and were normal. IV dexmedetomidine provided rapid symptom relief to prevent harm for the child, staff, and family on both occasions. Hindawi 2022-07-02 /pmc/articles/PMC9271000/ /pubmed/35818414 http://dx.doi.org/10.1155/2022/1843774 Text en Copyright © 2022 Chad Ward et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Ward, Chad
Khalid, Kiran
Rozette, Nicole
High-Dose Dexmedetomidine for Severe Hyperactive Delirium Secondary to Intravenous Levetiracetam on Two Separate Occasions in the Same Patient
title High-Dose Dexmedetomidine for Severe Hyperactive Delirium Secondary to Intravenous Levetiracetam on Two Separate Occasions in the Same Patient
title_full High-Dose Dexmedetomidine for Severe Hyperactive Delirium Secondary to Intravenous Levetiracetam on Two Separate Occasions in the Same Patient
title_fullStr High-Dose Dexmedetomidine for Severe Hyperactive Delirium Secondary to Intravenous Levetiracetam on Two Separate Occasions in the Same Patient
title_full_unstemmed High-Dose Dexmedetomidine for Severe Hyperactive Delirium Secondary to Intravenous Levetiracetam on Two Separate Occasions in the Same Patient
title_short High-Dose Dexmedetomidine for Severe Hyperactive Delirium Secondary to Intravenous Levetiracetam on Two Separate Occasions in the Same Patient
title_sort high-dose dexmedetomidine for severe hyperactive delirium secondary to intravenous levetiracetam on two separate occasions in the same patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271000/
https://www.ncbi.nlm.nih.gov/pubmed/35818414
http://dx.doi.org/10.1155/2022/1843774
work_keys_str_mv AT wardchad highdosedexmedetomidineforseverehyperactivedeliriumsecondarytointravenouslevetiracetamontwoseparateoccasionsinthesamepatient
AT khalidkiran highdosedexmedetomidineforseverehyperactivedeliriumsecondarytointravenouslevetiracetamontwoseparateoccasionsinthesamepatient
AT rozettenicole highdosedexmedetomidineforseverehyperactivedeliriumsecondarytointravenouslevetiracetamontwoseparateoccasionsinthesamepatient